Department of Chemistry and Biochemistry, Concordia University, Montreal, Québec, Canada.
Lady Davis Institute for Medical Research, McGill University, Montreal, Québec, Canada.
Sci Rep. 2018 Nov 19;8(1):17023. doi: 10.1038/s41598-018-34911-9.
Despite widespread resistance to many important antibiotics, the factors that govern the emergence and prevalence of antibiotic-resistant bacteria are still unclear. When exposed to antibiotic gradients in soft agar plates measuring as little as 1.25 × 11 cm we found that Escherichia coli rapidly became resistant to representatives from every class of antibiotics active against Gram-negative bacteria. Evolution kinetics were independent of the frequency of spontaneous mutations that confer antibiotic resistance or antibiotic dose-response curves, and were only loosely correlated to maximal antibiotic concentrations. Instead, rapid evolution required unrealized mutations that could markedly decrease antibiotic susceptibility. When bacteria could not evolve through these "high-impact" mutations, populations frequently bottlenecked, reducing the number of cells from which mutants could arise and prolonging evolution times. This effect was independent of the antibiotic's mechanism of action, and may affect the evolution of antibiotic resistance in clinical settings.
尽管人们普遍对抗生素的许多重要特性具有抗性,但控制抗生素抗性细菌出现和流行的因素仍不清楚。当我们在仅为 1.25×11cm 的软琼脂平板上测量抗生素梯度时,发现大肠杆菌很快对每一类针对革兰氏阴性菌的抗生素都产生了抗性。进化动力学与自发突变的频率无关,这些突变赋予了抗生素抗性或抗生素剂量反应曲线,并且与最大抗生素浓度仅松散相关。相反,快速进化需要未实现的突变,这些突变可以显著降低抗生素的敏感性。当细菌无法通过这些“高影响”突变进化时,种群经常会发生瓶颈效应,减少了可以产生突变体的细胞数量,并延长了进化时间。这种效应与抗生素的作用机制无关,可能会影响临床环境中抗生素耐药性的演变。